Amulyam Ayurveda Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 29-12-2024
- Paid Up Capital ₹ 0.20 M
as on 29-12-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -46.72%
(FY 2023)
- Profit -643.70%
(FY 2023)
- Ebitda -338.38%
(FY 2023)
- Net Worth -107.93%
(FY 2023)
- Total Assets -2.97%
(FY 2023)
About Amulyam Ayurveda
The Corporate was formerly known as Divyam Ayurveda Private Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Amara Ram and Jumma Devi serve as directors at the Company.
- CIN/LLPIN
U51909RJ2016PTC056245
- Company No.
056245
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
What products or services does Amulyam Ayurveda Private Limited offer?
Amulyam Ayurveda Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Herb Leaves, Cooking Spices and Masala, Vegetable Powders, Ayurvedic & Herbal Health Supplement, Herbal Juice, Common Disease Medicines, Thyroxine Sodium Tablets, Herbal Powder.
Who are the key members and board of directors at Amulyam Ayurveda?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amara Ram  | Director | 24-Nov-2023 | Current |
| Jumma Devi | Director | 24-Nov-2023 | Current |
Financial Performance of Amulyam Ayurveda.
Amulyam Ayurveda Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 46.72% decrease. The company also saw a substantial fall in profitability, with a 643.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 107.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amulyam Ayurveda?
In 2023, Amulyam Ayurveda had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amulyam Ayurveda?
Amulyam Ayurveda has a workforce of 19 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amulyam Ayurveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amulyam Ayurveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
